Position history for US BANCORP \DE\'s holdings in SYNDAX PHARMACEUTICALS INC
US BANCORP \DE\ holds 4,521 shares of SNDX (SYNDAX PHARMACEUTICALS INC), worth $94,986 as of 2025-Q4. SNDX represents 0.0% of US BANCORP \DE\'s portfolio.
Current Value
$94,986
Current Shares
4,521
Total Value Change
-$67,571
Total Shares Change
-3,397
Other major holders of SNDX: BNP PARIBAS FINANCIAL MARKETS, UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Unchanged |
| 4,521 |
0.0% |
| $94,986 |
| 0.0% |
| $20.74 |
0 |
| 2025-Q3 | Increased | 4,521 | +3.3% | $69,556 | 0.0% | $15.56 | 22 |
| 2025-Q2 | Decreased | 4,378 | -13.4% | $41,000 | 0.0% | $9.04 | 0 |
| 2025-Q1 | Decreased | 5,055 | -5.6% | $62,101 | 0.0% | $13.18 | 0 |
| 2024-Q4 | Decreased | 5,355 | -33.4% | $70,793 | 0.0% | $12.52 | 0 |
| 2024-Q3 | Increased | 8,043 | +1.6% | $154,828 | 0.0% | $18.89 | 23 |
| 2024-Q2 | Decreased | 7,918 | -2.8% | $162,557 | 0.0% | $20.53 | 0 |